Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The flavivirus envelope (E) protein is a structural glycoprotein found on the surface of flaviviruses, essential for viral entry and playing multiple roles throughout the viral life cycle. It mediates attachment to host receptors, membrane fusion during entry, virion assembly, and egress. The E protein consists of three domains (EDI, EDII, EDIII) connected by flexible hinges. EDII contains the fusion loop, and EDIII is involved in receptor binding. Glycosylation affects viral attachment, cell entry, virion stability, replication efficiency, and pathogenesis. The E protein is a major target for antiviral drug development and vaccine design due to its surface exposure and immunogenicity.
Inhibition of viral attachment, Inhibition of membrane fusion, Antibody-mediated neutralization, Targeted protein degradation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavivirus Envelope Protein (E protein).